Hims Stock Forecast
Last updated July 14, 2026 · Independent guide · Not medical advice
What does a Hims stock forecast actually mean?
A Hims stock forecast is an attempt to estimate where shares of Hims & Hers Health (NYSE: HIMS) might trade in the future, or what the company’s fundamentals might look like, based on a set of assumptions. Forecasts usually take the form of analyst price targets, ratings such as buy, hold, or sell, and financial models projecting revenue and earnings. This page explains, from an independent and educational standpoint, how those forecasts are built and how to think about them critically.
Before going further, a clear disclaimer: this is not investment advice, and nothing here is a recommendation to buy, sell, or hold any security. A forecast is an informed opinion about an uncertain future, not a promise. The purpose of this page is to help you understand the reasoning behind forecasts so you can evaluate them yourself rather than take any single number at face value.
Forecasts matter because they shape expectations, and expectations drive the price of a growth stock. But they are only as good as their assumptions. For the broader context on the stock, see our Hims Stock overview, and for the reporting that feeds these models, our Hims Earnings page.
How do analysts build a HIMS forecast?
Analysts generally follow a structured process to arrive at a price target. While methods differ, the common building blocks are:
- Model future revenue. Using historical results, company guidance, and industry trends, an analyst projects how fast revenue might grow over coming years.
- Estimate margins and earnings. From revenue, they project gross margin, operating costs, and ultimately earnings or cash flow.
- Choose a valuation method. Common approaches include discounted cash flow analysis or applying a valuation multiple (such as a multiple of revenue or earnings) to projected figures.
- Derive a price target. The output is an estimated fair value per share, often over a 12-month horizon.
Because each step involves assumptions, small changes in inputs can produce large differences in the final target. Two capable analysts can look at the same company and reach very different conclusions simply because they assume different growth rates or valuation multiples. This is why price targets for a stock like HIMS can span a wide range, and why a wide range is a signal of genuine uncertainty rather than a flaw.
What is the bull case for Hims stock?
A bull case is the optimistic scenario, the set of arguments for why the shares might do well. For Hims & Hers, a representative bull case has historically emphasized themes such as:
- Strong revenue growth driven by an expanding customer base.
- A growing subscriber base that produces recurring, subscription-style revenue.
- Improving margins as the business scales.
- The weight-loss and GLP-1 opportunity, which has been a notable growth driver; see our Hims Weight Loss overview.
- Category expansion, with the brand extending into additional health verticals.
The bull case is a collection of arguments, not a prediction. Each point rests on assumptions that may or may not hold, and even a well-reasoned bull case can be wrong if conditions change. Presenting it here is meant to illuminate the debate, not to endorse it.
What is the bear case for Hims stock?
A bear case is the cautionary scenario, the arguments for why the shares might struggle. A representative bear case for HIMS has historically pointed to:
- Competition in telehealth and consumer health from other well-funded players.
- Regulatory uncertainty, including evolving rules around telehealth prescribing and compounded medications.
- Category concentration, given reliance on the fast-moving weight-loss market.
- High customer-acquisition costs that can pressure profitability.
- Valuation risk, where a stock priced for strong growth can fall sharply if growth disappoints.
Just like the bull case, the bear case is a set of assumptions and arguments rather than a forecast to act on. A balanced reader weighs both sides and recognizes that reality often lands somewhere in between, or somewhere neither side anticipated. News around regulation and partnerships, discussed on our Hims News page, frequently shifts which case looks more compelling at a given moment.
”Buy or sell?” How should you frame that question?
Search interest often centers on whether HIMS is a “buy” or a “sell.” This page deliberately does not answer that question, because doing so would be a recommendation, and we do not give recommendations. Instead, it is more useful to reframe the question in terms of your own situation.
Whether any security is appropriate for you depends on factors that no generic web page can know: your financial goals, your time horizon, your tolerance for volatility, your existing holdings, and your need for the money. A stock that suits one person’s diversified, long-term portfolio may be entirely unsuitable for someone with a short horizon or low risk tolerance. These are personal considerations best worked through with a licensed financial professional who understands your circumstances.
The constructive takeaway is that “buy or sell” is not a property of the stock itself but a function of the fit between the stock and your plan. Educational content can lay out the arguments, as this page does, but the decision, and the responsibility for it, is yours.
How accurate are HIMS price targets?
It is worth being realistic about the track record of price targets, especially for volatile growth stocks. Targets are estimates built on assumptions, and they often prove imprecise. Analysts frequently revise their targets after earnings reports or major news, which tells you that targets are moving opinions rather than fixed truths.
A useful habit is to treat any single price target as one data point among many, and to pay attention to the spread of targets rather than fixating on the highest or lowest. A wide spread indicates that informed observers genuinely disagree about the future, which is a signal to be humble about any specific prediction. The table below summarizes how to read forecast elements without over-relying on them.
| Forecast element | What it is | How to treat it |
|---|---|---|
| Price target | Estimated fair value per share | One data point; check the date |
| Rating (buy/hold/sell) | A summary opinion | Understand the reasoning behind it |
| Consensus estimate | Average of analyst projections | Useful context, not a guarantee |
| Target spread | Range from lowest to highest | Wide spread signals uncertainty |
Any specific numbers you encounter should be treated as last-known or illustrative, not live. Confirm the current price and the latest ratings through a real-time source.
What risk factors belong in any forecast?
A responsible forecast, and a responsible reading of one, accounts for risk. For HIMS, the general risk categories that tend to appear include regulatory risk affecting telehealth and compounded medications, competitive risk in a crowded market, concentration risk tied to the weight-loss category, valuation risk if growth slows, and broad market risk that affects growth stocks regardless of company news.
These risks are illustrative rather than exhaustive, and the company’s own SEC filings contain the authoritative discussion of the factors management considers material. A forecast that ignores these risks, or a reader who does, is only seeing half the picture. Elevated short interest, covered on our Hims Short Interest page, is another dynamic that can influence how the stock behaves relative to any forecast.
Where can you find current forecasts, and how should you use them?
Aggregated analyst ratings and price targets are available on major financial data platforms, brokerage research portals, and some news outlets. Individual analyst reports contain the underlying reasoning in more depth, though many sit behind subscriptions. Whatever the source, always check the date, because forecasts change, sometimes within days of major news.
The healthiest way to use forecasts is as inputs to your own research rather than as conclusions. Read the primary sources first, form your own understanding of the business, and then use analyst views to challenge or refine your thinking. For the current stock price and valuation, use a live market data provider such as your brokerage or the NYSE website, since this page does not display live figures.
To continue exploring, see our Hims Stock overview, the Hims Earnings guide, Hims Short Interest, and Hims News. Our Hims and Hers company overview offers additional background. As a final reminder, this page is educational only and is not investment advice or a recommendation of any kind.